Comparing the Efficacy and Safety of Biosimilar Candidate Xlucane Versus Lucentis® in Patients With nAMD
Clinical trial NCT03805100 · COMPLETED
Trial details
- NCT number
- NCT03805100
- Sponsor
- Xbrane Biopharma AB
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-19
- Primary completion
- 2021-05-11
- Enrollment
- 582
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.